Cargando…
Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility
The signaling events that drive familial breast cancer (FBC) risk remain poorly understood. While the majority of genomic studies have focused on genetic risk variants, known risk variants account for at most 30% of FBC cases. Considering that multiple genes may influence FBC risk, we hypothesized t...
Autores principales: | Piccolo, Stephen R, Hoffman, Laura M, Conner, Thomas, Shrestha, Gajendra, Cohen, Adam L, Marks, Jeffrey R, Neumayer, Leigh A, Agarwal, Cori A, Beckerle, Mary C, Andrulis, Irene L, Spira, Avrum E, Moos, Philip J, Buys, Saundra S, Johnson, William Evan, Bild, Andrea H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812528/ https://www.ncbi.nlm.nih.gov/pubmed/26969729 http://dx.doi.org/10.15252/msb.20156506 |
Ejemplares similares
-
Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
por: Piccolo, Stephen R., et al.
Publicado: (2015) -
Window-of-Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker
por: Cohen, Adam L., et al.
Publicado: (2017) -
A pharmacogenomic method for individualized prediction of drug sensitivity
por: Cohen, Adam L, et al.
Publicado: (2011) -
Topsentinol L Trisulfate, a Marine Natural Product That Targets Basal-like and Claudin-Low Breast Cancers
por: El-Chaar, Nader N., et al.
Publicado: (2021) -
Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2017)